Enhanced weight loss from a dietary supplement containing standardized Phaseolus vulgaris extract in overweight men and women

Journal of Applied Research

Volumn 10, Issue 2, 2010, Pages 73-79

  Wu, Xiangming ^a   Xu, Xiaofeng ^b   Shen, Jianguo ^b   Perricone, Nicholas V ^c   Preuss, Harry G ^d  

^a ZHEJIANG UNIVERSITY   (China)

^b Physical Examination Center Hangzhou Convalescent Hospital   (China)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Amylase inhibitors; Bean extract; Obesity; Starch blockers; Weight loss

Indexed keywords

ANTIOBESITY AGENT; PHASEOLUS VULGARIS EXTRACT; PLACEBO; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD ANALYSIS; BODY MASS; BODY WEIGHT; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PHASEOLUS VULGARIS; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT REDUCTION;

EID: 77954901007     PISSN: 1537064X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. US Dept of Health and Human Services publication PHS 88-50210, Health objectives for the national prevalence of overweight among adolescents-United States 1988-91, 1994.
2. Popkin BM, Paeratakul S, Zhai F, Keyou G. A review of dietary and environmental correlates of obesity with emphasis on developing countries. Obes Res 3: 145S-153S, 1995.
3. WHO Consultation on Obesity. WHO, Geneva, Switzerland, 1997.
4. Guterman L: Obesity problem swells worldwide. The Chronicle of Higher Education. A18, March 8, 2002.
5. Bray GA. Obesity. In: Ziegler EE, Filer, Jr LJ Eds, Present Knowledge in Nutrition. Washington, D.C., ILSI Press, pp19-32, 1996.
6. Preuss HG, Gottlieb W: The Natural Fat Loss Pharmacy. Broadway Books, New York, NY, pp 1-260, 2007.
7. Agarwal S: Nutritional and Dietary approaches for weight management: an overview. In: Obesity: Epidemiology, Pathophysiology, and Prevention. (Eds) D Bagchi, HG Preuss, CRC Press, Fl pp 233-238, 2007.
8. Pawlak DB, Kushner JA, Ludwig DS: Effects of dietary glycaemic index on adiposity, glucose homeostasis, and plasma lipids in animals. Lancet 364:778-785, 2004.
9. Brehm BJ, Seeley RJ, Daniels SR, D'Allessio DA: A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Fam Pract 52:515-516, 2003.
10. Meckling KA, Gauthier M, Grubb R, Sanford J: Effects of a hypocaloric, low carbohydrate diet on weight loss, blood lipids, blood pressure, glucose tolerance, and body composition in free-living overweight women. Canad J Physiol Pharmacol 80:1095-1105, 2002.
11. Bell SJ, Van Ausdal W, Grachoski G: Appetite, body weight, health implications of a low glycemic load diet. In: Obesity: Epidemiology, Pathophysiology, and Prevention. (Eds) D Bagchi, HG Preuss, CRC Press, Fl, pp 233-238, 2007.
12. Layer P, Carlson GL, DiMagno EP: Partially purified white bean amylase inhibitor reduces starch digestion in vitro and inactivates intraduodenal amylase in humans. Gastroenterology 88:1895- 1902, 1985.
13. Layer P, Zinsmeister AR, DiMagno EP: Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans. Gastroenterology 91:41-48, 1986.
14. Higgins JA, Higbee DR, Donahoo WT, Brown IL, Bell ML, Bessesen DH: Resistant starch consumption promotes lipid oxidation. Nutrition and Metabolism 1:8, 2004.
15. Layer P, Rizza RA, Zinsmeister AR, Carlson GL, DiMagno EP: Effect of a purified amlase inhibitor on carbohydrate tolerance in normal subjects and patients with diabetes. Mayo Clin Proc 61:442- 447, 1986.
16. Boivin M, Zinsmeister AR, Go VI, DiMagno E: Effect of a purified amylase inhibitor on carbohydrate metabolism after a mixed meal in healthy humans. Mayo Clin Proc 62:249-255, 1987.
17. Brugge WR, Rosenfeld MS: Impairment of starch absorption by a potent amylase inhibitor. Am J Gastroenterology 82:718-722, 1987.
18. Boivin M, Flourie B, Rizza RA, Go VL: Gastrointestinal and metabolic effects of amylase inhibition in diabetics. Gastroenterology 94:387-394, 1988.
19. Birketvedt GS, Travis A, Langbakk B, Florholmen JR: Dietary supplementation with bean extract improves lipid profile in over weight and obese subjects. Nutrition 18;729-733, 2002.
20. Thom E: A randomized double-blind, placebocontrolled trial of a new weight reducing agent of natural origin. J Int Med Res 28:229-233, 2000.
21. Udani J, Hardy M, Madsen DC: Blocking carbohydrate absorption and weight loss: a clinical trial using Phase 2 brand proprietary fractionated white bean extract. Altern Med Rev 9:63-69, 2004.
22. Celleno L, Perricone NV, Preuss HG: Effect of a dietary supplement containing standardized Phaseolus vulgaris extract on the body composition of overweight men and women. Int J Med Sci 4:45-52, 2007.
23. Preuss HG, Echard B, Talpur N, Talpur F, Stohs S: Inhibition of starch and sucrose gastrointestinal absorption in rats by various dietary supplements alone and combined. Acute studies Int J Med Sci 4:196-202, 2007.
24. Preuss HG, Echard B, Talpur N, Talpur F, Stohs S: Inhibition of starch and sucrose gastrointestinal absorption in rats by various dietary supplements alone and combined. Subchronic studies. Int J Med Sci 4:209-215, 2007.
25. Frels JM, Rupnow JH: Purification and partial characterization of two alpha-amylase inhibitors from black bean (Phaseolus vulgaris). J Food Biochem 1:385-401, 1984.
26. Gibbs B, Alli I: Characterization of a purified alpha-amylase inhibitor from white kidney bean (Phaseolus vulgaris). Food Research International. 31:217-225, 1998.
27. Hansawasdi C, Kawabata J, Kasai T: Alpha-amylase inhibitors from roselle (Hibiscus sabdariffa Linn.) tea. Biosci Biotechnol Biochem 64:1041- 1043, 2000.
28. Hansawadi C, Kawabata J, Kasai T: Hibiscus acid as an inhibitor of starch digestion in the Caco-2 cell model system. Biosci Biotechnol Biochem 65:2087-2089, 2001.
29. Santimone M, Koukiekolo R, Moreau Y, Le Berre V, Rouge P, Marchis-Mouren G, Desseaux V: Porcine pancreatic alpha-amylase inhibition by the kidney bean (Phaseolus vulgaris) inhibitor (Alpha-AII) and structural changes in the alphaamylase inhibitor complex. Biochim Biophys Acta 1696:181-190, 2004.
30. Macdonald I: Carbohydrates. In Modern Nutrition in Health and Disease. Edited by Shils ME, Olson JA, Shike M. Pennsylvania: Lea & Febiger; pp 36-46, 1994.
31. Chokshi D: Toxicity studies of Blokal, a dietary supplement containing Phase 2 Starch Neutralizer (Phase 2), a standardized extract or the common white kidney bean (Phaseolus vulgaris). Int J Toxicol 25:361-371, 2006.
32. Chokshi D: Subchronic oral toxicity of a standardized white kidney bean (Phaseolus vulgaris) in rats. Food Chem Toxicol. 45:32-40, 2007.
33. Meiss DE: Phaseolus vulgaris and alpha-amylase inhibition. In: Obesity: Epidemiology, Pathophysiology, and Prevention. (Eds) D Bagchi, HG Preuss, CRC Press, Fl, pp 423-432, 2007.
34. Kaats GR, Michelak J E, Preuss HG: An evaluation of the efficacy and safety of a chitosan fiber product. J Am Coll Nutr 25:389-394, 2006.
35. Udani J, Hardy M, Kavoussi B: Dietary supplement carbohydrate inhibitors: a review of the literature. In: Obesity: Epidemiology, Pathophysiology, and Prevention. (Eds) D Bagchi, HG Preuss, CRC Press, Fl, pp 279-298, 2007.
36. Obiro WC, Zhang T, Jiang B: The nutraceutical role of the Phaseolus vulgaris alpha-amylase inhibitor. Br J Nutr 100:1-12, 2008.